Panel Discussion – Thinking Strategically About What Targets You Select
Time: 3:30 pm
day: Day One
- Understanding where your target choice and ADC fits into the ADC and wider oncology landscape?
- How do you differentiate yourself through using improved linker-payload technologies on previously validated targets?
- Balancing risk in your pipeline through your target choice
- Novel targets or previously validated targets?
- Discussing the role of future HER2 ADCs